An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 2, 2015, Pages 485-500

  Ippolito, Chiara ^a   Segnani, Cristina ^a   Errede, Mariella ^b   Virgintino, Daniela ^b   Colucci, Rocchina ^a   Fornai, Matteo ^a   Antonioli, Luca ^a   Blandizzi, Corrado ^a   Dolfi, Amelio ^a   Bernardini, Nunzia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

DNBS; Colonic inflammatory fibrosis; Myenteric ganglia; Neuromuscular compartment; Wall remodelling

Indexed keywords

RATTUS;

ANIMAL; COLITIS; COLON; INFLAMMATION; MALE; PATHOLOGY; RAT; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT;

ANIMALS; COLITIS; COLON; INFLAMMATION; MALE; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84921819093     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12428     Document Type: Article

References (71)

1. Rieder F, Kessler S, Sans M, et al. Animal models of intestinal - New tools for understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol. 2012; 303: G786-801.
2. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004; 50: 81-92.
3. Neunlist M, Aubert P, Toquet C, et al. Changes in chemical coding of myenteric neurons in ulcerative colitis. Gut. 2003; 52: 84-90.
4. Villanacci V, Bassotti G, Nascimbeni R, et al. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil. 2008; 20: 1009-16.
5. Bernardini N, Segnani C, Ippolito C, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med. 2012; 16: 318-27.
6. Yamagata M, Mikami T, Tsuruta T, et al. Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion. 2011; 84: 12-21.
7. Bernardini N, Segnani C, Ippolito C, et al. Connective remodeling of the colonic neuromuscular compartment of patients with ulcerative colitis. Neurogastroenterol Motil. 2012; 24: 67.
8. Gordon IO, Agrawal N, Goldblum JR, et al. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis. 2014; 1-9.
9. Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2011; 300: G677-83.
10. Hogaboam CM, Jacobson K, Collins SM, et al. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 1995; 268: G673-84.
11. Marlow SL, Blennrhassett MG. Deficient innervation characterizes intestinal strictures in a rat model of colitis. Exp Mol Pathol. 2006; 80: 54-66.
12. San-Miguel B, Crespo I, Kretzmann NA, et al. Glutamine prevents fibrosis development in rats with colitis induced by 2, 4, 6 trinitrobenzene sulfonic acid. J Nutr. 2010; 140: 1065-71.
13. Stidham RW, Xu J, Johnson LA, et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease. Gastroenterol. 2011; 141: 819-26.
14. Zhu MY, Lu YM, Ou YX, et al. Dynamic progress of 2, 4, 6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model. J Digest Dis. 2012; 13: 421-9.
15. Goyal N, Rana A, Ahlawat A, et al. Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014; 22: 219-33.
16. Fornai M, Blandizzi C, Antonioli L, et al. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation. J Pharmacol Exp Ther. 2006; 317: 938-45.
17. Antonioli L, Fornai M, Colucci R, et al. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther. 2007; 322: 435-52.
18. Giron MC, Bin A, Brun P, et al., et al. Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway. Gastroenterology. 2008; 134: 1116-26.
19. Nair DG, Han TY, Lourenssen S, et al. Proliferation modulates intestinal smooth muscle phenotype in vitro and in colitis in vivo. Am J Physiol Gastrointest Liver Physiol. 2011; 300: G903-13.
20. Virgintino D, Errede M, Rizzi M, et al. The CXCL12/CXCR4/CXCR7 ligand-receptor system regulates neuro-glio-vascular interactions and vessel growth during human brain development. J Inherit Metab Dis. 2013; 36: 455-66.
21. Ippolito C, Segnani C, De Giorgio R, et al. Quantitative evaluation of myenteric ganglion cells in normal human left colon: implications histopathological analysis. Cell Tissue Res. 2009; 336: 191-201.
22. Miyake T, Okada M, Kitamura T. Reactive proliferation of astrocytes studied by immunohistochemistry for proliferating cell nuclear antigen. Brain Res. 1992; 590: 300-2.
23. Sarna SK. Colonic motility: from bench side to beside. San Rafael: Morgan and Claypool Life Science; 2010.
24. Quigley EM. What we have learned about colonic motility: normal and disturbed. Curr Opin Gastroenterol. 2010; 26: 53-60.
25. Padol I, Huang JQ, Hogaboam CM. Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. Eur J Gastroenterol Hepathol. 2000; 12: 257-65.
26. Vasina V, Abu-Gharbieh E, Barbara G, et al. The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol Motil. 2008; 20: 1034-41.
27. Vallance BA, Gunawan MI, Hewlett B, et al. TGF-β1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G116-28.
28. Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflamm. 2010; 7: 37-48.
29. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989; 96: 795-803.
30. Martin AR, Villegas I, Alarćon de la Lastra C. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. Inflamm Res. 2005; 54: 145-51.
31. Li C, Flynn RS, Grider JR, et al. Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide. Inflamm Bowel Dis. 2013; 19: 2829-39.
32. Leung G, Wang A, Fernando M, et al. Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10. Am J Physiol Gastrointest Liver Physiol. 2013; 304: G781-92.
33. Li P, Liang M-L, Zhu Y, et al. Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts. World J Gastroenterol. 2014; 20: 4648-61.
34. Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol. 1999; 155: 1051-7.
35. Poli E, Lazzaretti M, Grandi D, et al. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem Res. 2001; 26: 1085-93.
36. Boyer L, Ghoreishi M, Templeman V, et al. Myenteric plexus injury and apoptosis in experimental colitis. Auton Neurosci-Basic Clin. 2005; 117: 41-53.
37. von Boyen GB, Steinkamp M, Reinshagen M, et al. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut. 2004; 53: 222-8.
38. von Boyen GB, Schulte N, Pflüger C, et al. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 2011; 11: 3.
39. Bradley JS, Parr EJ, Sharkey KA. Effect of inflammation on cell proliferation in the myenteric plexus of the guinea-pig ileum. Cell Tissue Res. 1997; 289: 455-61.
40. Ruhl A, Nasser Y, Sharkey KA. Enteric glia. Neurogastroenterol Motil. 2004; 16: 44-9.
41. Schäfer KH, Van Ginneken C, Copray S. Plasticity and neural stem cells in the enteric nervous system. Anat Rec. 2009; 292: 1940-52.
42. Curtis MA, Penney EB, Pearson AG, et al. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci USA. 2003; 100: 9023-7.
43. Kruger GM, Mosher JT, Bixby S, et al. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron. 2002; 35: 657-9.
44. Wiese C, Rolletschek A, Kania G, et al. Nestin expression - a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004; 61: 2510-22.
45. Rieder F, Fiocchi C. Intestinal fibrosis in IBD a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009; 6: 228-35.
46. Cromer WE, Mathis JM, Granger DN, et al. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol. 2011; 17: 578-93.
47. Rauch U, Klotz M, Maas-Omlor S, et al. Expression of intermediate filament proteins and neuronal markers in the human fetal gut. J Histochem Cytochem. 2006; 54: 39-46.
48. Kishaba Y, Matsubara D, Niki T. Heterogeneous expression of nestin in myofibroblasts of various human tissues. Pathol Int. 2010; 60: 378-85.
49. Vanderwinden JM, Gillard K, De Laet M-H, et al. Distribution of the intermediate filament nestin in the muscularis propria of the human gastrointestinal tract. Cell Tissue Res. 2002; 309: 261-8.
50. Suciu LC, Popescu BO, Kostin S, et al. Platelet-derived growth factor receptor-β-positive telocytes in skeletal muscle interstitium. J Cell Mol Med. 2012; 16: 701-7.
51. Di Sebastiano P, Grossi L, Di Mola FF, et al. SR 140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Digest Dis Sci. 1999; 44: 439-44.
52. Miampamba M, Sharkey KA. Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol Motil. 1998; 10: 315-29.
53. O'Connor TM, O'Connell J, O'Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol. 2004; 201: 167-80.
54. Gross KJ, Pothoulakis C. Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 918-32.
55. Liu L, Shang F, Markus I, et al. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. J Pharmacol Exp Ther. 2002; 302: 627-35.
56. Grider JR, Heuckeroth RO, Kuemmerle JF, et al. Augmentation of the ascending component of the peristaltic reflex and substance P release by glial cell line-derived neurotrophic factor (GDNF). Neurogastroenterol Motil. 2010; 22: 779-86.
57. Keränen U, Kiviluoto T, Järvinen H, et al. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Digest Dis Sci. 1995; 40: 2250-8.
58. Koon HW, Shih D, Karagiannides I, et al. Substance P modulates colitis-associated fibrosis. Am J Pathol. 2010; 177: 2300-9.
59. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, et al. ANO1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1370-81.
60. -conductance in smooth muscle. Am J Physiol Cell Physiol. 1996; 271: C435-54.
61. Huang F, Rock JR, Hafer BD, et al. Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc Natl Acad Sci USA. 2009; 106: 21413-8.
62. Sanders KM, Zhu MH, Britton F, et al. Anoctamins and gastrointestinal smooth muscle excitability. Exp Physiol. 2012; 97: 200-6.
63. Davis AJ, Forrest AS, Jepps TA, et al. Expression profile and protein translation of TMEM16A in murine smooth muscle. Am J Physiol Cell Physiol. 2010; 299: C948-59.
64. Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 2008; 322: 590-4.
65. Iqbal J, Tonta MA, Mitsui R, et al. Potassium and ANO1/ TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvis. Br J Pharmacol. 2012; 165: 2389-408.
66. Rock JR, Futtner CR, Harfe BD. The transmembrane protein TMEM16A is required for normal development of the murine trachea. Dev Biol. 2008; 321: 141-9.
67. Duran C, Hartzell HC. Physiological roles and diseases of TMEM16/Anoctamin proteins: are they all chloride channels? Acta Pharmacol Sin. 2011; 32: 685-92.
68. Forrest AS, Joyce TC, Huebner ML, et al. Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension. Am J Physiol Cell Physiol. 2012; 303: C1229-43.
69. - channel in airway smooth muscle contributes to airway hyperresponsiveness. Am J Respir Crit Care Med. 2013; 187: 374-81.
70. Bulley S, Neeb ZP, Burris SK, et al. TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries. Circ Res. 2012; 111: 1027-36.
71. Namkung W, Phuan PW, Verkman AS. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium- activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem. 2011; 286: 2365-74.